Augmenter of liver regeneration knockout aggravates tubular ferroptosis and macrophage activation by regulating carnitine palmitoyltransferase‐1A‐induced lipid metabolism in diabetic nephropathy

Yuanyuan Zhang,Zheng Zhang,Lili Huang,Chunxia Wang,Pengfei Yang,Ling Zhang,Xiaohui Liao
DOI: https://doi.org/10.1111/apha.14159
IF: 7.523
2024-05-22
Acta Physiologica
Abstract:Aim Ferroptosis is a novel type of programmed cell death that performs a critical function in diabetic nephropathy (DN). Augmenter of liver regeneration (ALR) exists in the inner membrane of mitochondria, and inhibits inflammation, apoptosis, and oxidative stress in acute kidney injury; however, its role in DN remains unexplored. Here, we aimed to identify the role of ALR in ferroptosis induction and macrophage activation in DN. Methods The expression of ALR was examined in DN patients, db/db DN mice, and HK‐2 cells treated with high glucose (HG). The effects of ALR on ferroptosis and macrophage activation were investigated with ALR conditional knockout, lentivirus transfection, transmission electron microscopy, qRT‐PCR and western blotting assay. Mass spectrometry and rescue experiments were conducted to determine the mechanism of ALR. Results ALR expression was reduced in the kidney tissues of DN patients and mice, serum of DN patients, and HG‐HK‐2 cells. Moreover, the inhibition of ALR promoted ferroptosis, macrophage activation, and DN progression. Mechanistically, ALR can directly bind to carnitine palmitoyltransferase‐1A (CPT1A), the key rate‐limiting enzyme of fatty acid oxidation (FAO), and inhibit the expression of CPT1A to regulate lipid metabolism involving FAO and lipid droplet‐mitochondrial coupling in DN. Conclusion Taken together, our findings revealed a crucial protective role of ALR in ferroptosis induction and macrophage activation in DN and identified it as an alternative diagnostic marker and therapeutic target for DN.
physiology
What problem does this paper attempt to address?